{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:17:37Z","timestamp":1787987857640,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ijpharm.2016.09.061","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T11:46:30Z","timestamp":1474544790000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion"],"prefix":"10.1016","volume":"515","author":[{"given":"Isabel","family":"Lozoya-Agullo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Zur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Beig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gonz\u00e1lez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Merino-Sanju\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Gonz\u00e1lez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marival","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arik","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.09.061_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/clpt.2011.109","article-title":"Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy","volume":"90","author":"Amidon","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/js980370+","article-title":"Validation of a biophysical drug absorption model by the PATQSAR system","volume":"88","author":"Bermejo","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0020","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0025","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1023\/A:1011981317451","article-title":"Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats","volume":"15","author":"Chiou","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11095-008-9789-7","article-title":"Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein","volume":"26","author":"Dahan","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/mp800088f","article-title":"Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs","volume":"6","author":"Dahan","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1208\/s12248-012-9337-6","article-title":"The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs","volume":"14","author":"Dahan","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0045","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: provisional BCS classification of the world\u2019s top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0050","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1124\/dmd.109.028282","article-title":"Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine","volume":"37","author":"Dahan","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejps.2008.10.013","article-title":"Segmental-dependent membrane permeability along the intestine following oral drug administration: evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat","volume":"36","author":"Dahan","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0060","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/mp100175a","article-title":"High-permeability criterion for BCS classification: segmental\/pH dependent permeability considerations","volume":"7","author":"Dahan","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0065","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/mp300140h","article-title":"The fraction dose absorbed, in humans, and high jejunal human permeability relationship","volume":"9","author":"Dahan","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0070","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/mp300140h","article-title":"The fraction dose absorbed, in humans, and high jejunal human permeability relationship","volume":"9","author":"Dahan","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0075","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/jps.23977","article-title":"Biowaiver monographs for immediate-release solid oral dosage forms: codeine phosphate","volume":"103","author":"Dahan","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0080","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/jps.2600581006","article-title":"Drug absorption: I. An in situ rat gut technique yielding realistic absorption rates","volume":"58","author":"Doluisio","year":"1969","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0085","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1208\/s12248-013-9462-x","article-title":"Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine","volume":"15","author":"Fairstein","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bdd.548","article-title":"In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results","volume":"28","author":"Gonzalez-Alvarez","year":"2007","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0095","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1021\/mp060042f","article-title":"The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests","volume":"3","author":"Kim","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02354289","article-title":"Permeability and clearance views of drug absorption: a commentary","volume":"23","author":"Lennernas","year":"1995","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0105","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.addr.2007.06.016","article-title":"Animal data: the contributions of the ussing chamber and perfusion systems to predicting human oral drug delivery in vivo","volume":"59","author":"Lennernas","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp4003392","article-title":"Human in vivo regional intestinal permeability: importance for pharmaceutical drug development","volume":"11","author":"Lennernas","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejps.2013.08.025","article-title":"Regional intestinal drug permeation: biopharmaceutics and drug development","volume":"57","author":"Lennernas","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.01.014","article-title":"In-situ intestinal rat perfusions for human fabs prediction and BCS permeability class determination: investigation of the single-pass vs. the Doluisio experimental approaches","volume":"480","author":"Lozoya-Agullo","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0125","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF01067967","article-title":"Studies on the reliability of a bihyperbolic functional absorption model: I. Ring-substituted anilines","volume":"14","author":"Martin-Villodre","year":"1986","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/00970002042006005","article-title":"A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals","volume":"42","author":"Martinez","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0135","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1208\/s12248-015-9758-0","article-title":"Translating human effective jejunal intestinal permeability to surface-dependent intrinsic permeability: a pragmatic method for a more mechanistic prediction of regional oral drug absorption","volume":"17","author":"Olivares-Morales","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/mp500553b","article-title":"Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification","volume":"12","author":"Ozawa","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1208\/s12248-008-9040-9","article-title":"Summary workshop report: bioequivalence, biopharmaceutics classification system, and beyond","volume":"10","author":"Polli","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0939-6411(99)00057-0","article-title":"Pharmacokinetics, bioavailability and absorption of flumequine in the rat","volume":"48","author":"Ruiz-Garcia","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","article-title":"In vivo methods for drug absorption\u2014comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects","volume":"57","author":"Sj\u00f6gren","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0160","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/mp500834v","article-title":"Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data","volume":"12","author":"Sjogren","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0165","first-page":"206P","article-title":"Absorption of drugs from human jejunum and ileum","volume":"26","author":"Sutcliffe","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejps.2014.05.016","article-title":"Validation of phenol red versus gravimetric method for water reabsorption correction and study of gender differences in Doluisio\u2019s absorption technique","volume":"62","author":"Tugcu-Demiroz","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/js970218s","article-title":"Membrane transport of drugs in different regions of the intestinal tract of the rat","volume":"87","author":"Ungell","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0180","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1021\/mp2004912","article-title":"pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery","volume":"9","author":"Varma","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0185","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1023\/A:1016473601633","article-title":"Biopharmaceutics classification system: the scientific basis for biowaiver extensions","volume":"19","author":"Yu","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0190","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1021\/mp500152y","article-title":"The low\/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol","volume":"11","author":"Zur","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2013.11.007","article-title":"The complexity of intestinal permeability: assigning the correct BCS classification through careful data interpretation","volume":"61","author":"Zur","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.061_bib0200","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2015.05.002","article-title":"The biopharmaceutics of successful controlled release drug product: segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract","volume":"489","author":"Zur","year":"2015","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316308912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316308912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T06:57:59Z","timestamp":1536389879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316308912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0378517316308912"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.09.061","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.09.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}